|
US20030013772A1
(en)
*
|
2000-02-23 |
2003-01-16 |
Murphy Michael A. |
Composition, synthesis and therapeutic applications of polyamines
|
|
US20050085555A1
(en)
*
|
1997-08-21 |
2005-04-21 |
Murphy Michael A. |
Composition, synthesis and therapeutic applications of polyamines
|
|
AU4678300A
(en)
|
1999-04-30 |
2000-11-17 |
Slil Biomedical Corporation |
Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
|
|
JP4743673B2
(ja)
*
|
1999-04-30 |
2011-08-10 |
プロゲン ファーマシューティカルズ， インコーポレイテッド |
ポリアミンおよび治療におけるそれらの使用
|
|
AU2001297817A1
(en)
|
2000-11-08 |
2002-11-25 |
Eli Lilly And Company |
Antiviral therapies using polyamine or polyamine analog-amino acid conjugates
|
|
IL161428A0
(en)
*
|
2001-10-16 |
2004-09-27 |
Slil Biomedical Corp |
Oligoamine derivatives, methods for the production thereof and pharmaceutical compositions containing the same
|
|
JP2004189714A
(ja)
*
|
2002-12-09 |
2004-07-08 |
Rasanen Tiina-Liisa |
すい臓炎の治療と予防ならびに肝臓再生機能の誘導のための薬剤
|
|
JP4860700B2
(ja)
|
2005-09-20 |
2012-01-25 |
シェーリング コーポレイション |
ヒスタミンＨ３アンタゴニストとして有用な、１−［［１−［（２−アミノ−６−メチル−４−ピリジニル）メチル］−４−フルオロ−４−ピペリジニル］カルボニル］−４−［２−（２−ピリジニル）−３Ｈ−イミダゾ［４，５−ｂ］ピリジン−３−イル］ピペリジン
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
EP2527360B1
(en)
|
2007-06-04 |
2015-10-28 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
FR2917971B1
(fr)
|
2007-06-28 |
2009-10-23 |
Engelhard Lyon Soc Par Actions |
Composition amincissante
|
|
US8153611B2
(en)
*
|
2007-06-28 |
2012-04-10 |
Basf Beauty Care Solutions France S.A.S. |
Use of sulfated oligosaccharides as slimming cosmetic ingredients
|
|
ES2616291T3
(es)
*
|
2007-06-28 |
2017-06-12 |
Basf Beauty Care Solutions France Sas |
Composición adelgazante
|
|
CN101910151A
(zh)
|
2007-10-22 |
2010-12-08 |
先灵公司 |
双环杂环衍生物及其作为gpr119活性调节剂的用途
|
|
US20110065671A1
(en)
|
2008-05-19 |
2011-03-17 |
Harris Joel M |
Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
|
|
EP2810951B1
(en)
|
2008-06-04 |
2017-03-15 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
EP3241839B1
(en)
|
2008-07-16 |
2019-09-04 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
RU2392933C2
(ru)
*
|
2008-07-18 |
2010-06-27 |
Учреждение Российской Академии Медицинских Наук Научно-исследовательский институт экспериментальной медицины Северо-западного отделения РАМН (НИИЭМ СЗО РАМН) |
Средство, обладающее гиполипидемическими свойствами
|
|
US20110166124A1
(en)
|
2008-07-23 |
2011-07-07 |
Mccormick Kevin D |
Tricyclic spirocycle derivatives and methods of use
|
|
EP2350020B1
(en)
|
2008-10-03 |
2014-08-13 |
Merck Sharp & Dohme Corp. |
Spiro-imidazolone derivatives as glucagon receptor antagonists
|
|
WO2010045306A2
(en)
|
2008-10-16 |
2010-04-22 |
Schering Corporation |
Azine derivatives and methods of use thereof
|
|
WO2010075069A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Bicyclic pyranone derivatives as nicotinic acid receptor agonists
|
|
US20110245209A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
|
EP2379564A1
(en)
|
2008-12-19 |
2011-10-26 |
Schering Corporation |
Bicyclic heterocyclic derivatives and methods of use thereof
|
|
US20110245267A1
(en)
|
2008-12-19 |
2011-10-06 |
Schering Plough Corporation |
Piperidine and piperazine derivatives and methods of use thereof
|
|
WO2010075271A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
JP2012513469A
(ja)
|
2008-12-23 |
2012-06-14 |
シェーリング コーポレイション |
ピリミジン誘導体及びその使用法
|
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
US20120022057A1
(en)
|
2009-03-18 |
2012-01-26 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacyglycerol acyltransferase
|
|
EP2414348B1
(en)
|
2009-04-03 |
2013-11-20 |
Merck Sharp & Dohme Corp. |
Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
|
|
AR076024A1
(es)
|
2009-04-03 |
2011-05-11 |
Schering Corp |
Derivados de heterociclos biciclicos puenteados y metodos de uso de los mismos
|
|
WO2010144664A1
(en)
|
2009-06-12 |
2010-12-16 |
Schering Corporation |
Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
|
|
US20120172369A1
(en)
|
2009-09-14 |
2012-07-05 |
Ting Pauline C |
Inhibitors of diacylglycerol acyltransferase
|
|
WO2011043994A1
(en)
|
2009-10-08 |
2011-04-14 |
Schering Corporation |
Inhibitors of fatty acid binding protein (fabp)
|
|
US9409918B2
(en)
|
2009-10-29 |
2016-08-09 |
Merck Sharp & Dohme Corp. |
Bridged bicyclic piperidine derivatives and methods of use thereof
|
|
US20120232073A1
(en)
|
2009-11-23 |
2012-09-13 |
Santhosh Francis Neelamkavil |
Fused bicyclic pyrimidine derivatives and methods of use thereof
|
|
US8912206B2
(en)
|
2009-11-23 |
2014-12-16 |
Merck Sharp & Dohme Corp. |
Pyrimidine ether derivatives and methods of use thereof
|
|
US9301929B2
(en)
|
2009-11-24 |
2016-04-05 |
Merck Sharp & Dohme Corp. |
Substituted biaryl derivatives and methods of use thereof
|
|
WO2011113060A2
(en)
*
|
2010-03-12 |
2011-09-15 |
Trana Discovery, Inc. |
Antiviral compounds and methods of use thereof
|
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
CA2905438A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
ITMI20130555A1
(it)
*
|
2013-04-09 |
2014-10-10 |
Giuliani Spa |
Composizione farmaceutica o cosmetica per contrastare l¿invecchiamento della pelle attraverso un¿azione antiinfiammatoria
|
|
SI3004138T1
(sl)
|
2013-06-05 |
2024-07-31 |
Bausch Health Ireland Limited |
Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
|